EI
MDGL icon

Ellevest Inc’s Madrigal Pharmaceuticals MDGL Stock Holding History

Ellevest Inc’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7
Closed -$1.7K – 1100
2023
Q1 		$1.7K Buy
+7
New +$1.91K ﹤0.01% 1476
2022
Q2 		– Sell
-46
Closed -$5K – 1560
2022
Q1 		$5K Hold
46
– – ﹤0.01% 1039
2021
Q4 		$4K Buy
46
+25
+119% +$2.05K ﹤0.01% 1055
2021
Q3 		$2K Sell
21
-12
-36% -$1.04K ﹤0.01% 1150
2021
Q2 		$3K Buy
33
+2
+6% +$237 ﹤0.01% 978
2021
Q1 		$4K Hold
31
– – ﹤0.01% 949
2020
Q4 		$3K Buy
31
+10
+48% +$1.22K ﹤0.01% 916
2020
Q3 		$2K Hold
21
– – ﹤0.01% 913
2020
Q2 		$2K Hold
21
– – ﹤0.01% 896
2020
Q1 		$1K Buy
+21
New +$1.75K ﹤0.01% 926

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Ellevest Inc's MDGL Position: Q2 2023 in Review

Ellevest Inc sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2023, closing a stake of 7 shares — an estimated $1.7K sold.

Ellevest Inc first reported a position in MDGL in Q1 2020 and held it in 10 quarters. The position peaked at $5K in Q1 2022. 208 funds tracked by Wall St. Rank hold MDGL as of Q2 2023.

  • Ellevest Inc reported no remaining Madrigal Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 7 Madrigal Pharmaceuticals shares in Q2 2023, an estimated $1.7K.
  • Ellevest Inc first reported a position in Madrigal Pharmaceuticals in Q1 2020 and held it in 10 quarters.
  • Ellevest Inc's Madrigal Pharmaceuticals position peaked at $5K in Q1 2022.
  • 208 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.